American journal of therapeutics最新文献

筛选
英文 中文
Urinary Alkalinization for Salicylate Poisoning Is Infrequently Measured nor Achieved. 尿碱化对水杨酸中毒的影响很少被测量或实现。
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2025-04-23 DOI: 10.1097/MJT.0000000000001930
Bernard Weigel, Chanell Davis, Sean M Bryant
{"title":"Urinary Alkalinization for Salicylate Poisoning Is Infrequently Measured nor Achieved.","authors":"Bernard Weigel, Chanell Davis, Sean M Bryant","doi":"10.1097/MJT.0000000000001930","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001930","url":null,"abstract":"<p><strong>Background: </strong>Urinary alkalinization is a key intervention for salicylate poisoning, and clinical guidelines recommend serial urinary pH measurements during treatment.</p><p><strong>Study question: </strong>How frequently are urine pH measurements obtained, and how often is alkalinization achieved when managing salicylate poisoning with sodium bicarbonate therapy?</p><p><strong>Study design: </strong>This is a retrospective poison center study. Salicylate cases managed by a regional poison center for a 5-year period (2019-2023) were analyzed. Inclusion criteria included all patients receiving bicarbonate therapy for salicylate concentrations >30 mg/dL that were managed in a health care facility. Patients requiring hemodialysis were excluded to eliminate confounding factors.</p><p><strong>Measures and outcomes: </strong>The primary outcome was the documentation of a urine pH in the poison center chart. Secondary outcomes included the frequency of urine pH measurements and the achievement of a urinary pH ≥7.5. Data were analyzed using descriptive statistics. Multivariable logistic regression was performed to determine variables associated with increased odds of urine pH measurement.</p><p><strong>Results: </strong>Among 352 cases, urine pH was documented in 144 (41%). Median urine pH values ranged from 6.0 to 8.5 across serial measurements. Urinary alkalinization (pH ≥7.5) was achieved in 34% of cases with documented urine pH. Higher peak salicylate concentrations were associated with increased odds of urine pH measurement (OR = 1.04, P < 0.001). Verbal recommendations significantly increased the likelihood of pH measurement (OR = 3.43, P < 0.001). Formal guidelines faxed or emailed to clinicians, ICU admission, and toxicology consultation were not significant predictors of urine pH testing.</p><p><strong>Conclusions: </strong>Urine pH was measured in fewer than half of cases, indicating poor adherence to guidelines recommending urinary pH monitoring during alkalinization therapy. Verbal recommendations were more effective than written guidelines in promoting pH measurement. Further investigation into the clinical utility and adherence barriers of urine pH measurement is warranted.</p>","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143965448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Topical Finasteride and Oral Finasteride in the Treatment of Androgenic Alopecia. A Systemic Review and Meta-Analysis. 外用非那雄胺与口服非那雄胺治疗雄激素性脱发的比较。系统评价和荟萃分析。
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2025-04-22 DOI: 10.1097/MJT.0000000000001887
Syed Ali Arsal, Aashish Kumar, Umer Iqbal, Muhammad Aniq Amir, Muhammad Maaz, Muhammad Abrar Amir
{"title":"Comparison of Topical Finasteride and Oral Finasteride in the Treatment of Androgenic Alopecia. A Systemic Review and Meta-Analysis.","authors":"Syed Ali Arsal, Aashish Kumar, Umer Iqbal, Muhammad Aniq Amir, Muhammad Maaz, Muhammad Abrar Amir","doi":"10.1097/MJT.0000000000001887","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001887","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143958207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transient Hyperprolactinemia After a Single Low-Dose PRN Olanzapine ODT in a Low-Functioning Autistic Boy. 低功能自闭症男孩单次低剂量PRN奥氮平ODT后短暂性高泌乳素血症。
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2025-04-22 DOI: 10.1097/MJT.0000000000001942
Ahmed Naguy, Nadyah Alayadhi, Dalal Elsori, Bibi Alamiri
{"title":"Transient Hyperprolactinemia After a Single Low-Dose PRN Olanzapine ODT in a Low-Functioning Autistic Boy.","authors":"Ahmed Naguy, Nadyah Alayadhi, Dalal Elsori, Bibi Alamiri","doi":"10.1097/MJT.0000000000001942","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001942","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143952462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of the Reporting Quality of Randomized Controlled Trials That Investigate the Efficacy of Curcumin for Treating Depression. 姜黄素治疗抑郁症疗效的随机对照试验报告质量评价。
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2025-04-17 DOI: 10.1097/MJT.0000000000001958
Alexandra Valera, Theodoros Mprotsis, Chrysoula Doxani
{"title":"Assessment of the Reporting Quality of Randomized Controlled Trials That Investigate the Efficacy of Curcumin for Treating Depression.","authors":"Alexandra Valera, Theodoros Mprotsis, Chrysoula Doxani","doi":"10.1097/MJT.0000000000001958","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001958","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143960471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Decrease of PD-L1 Expression Affects the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Lung Squamous Cell Carcinoma. PD-L1表达降低影响肺鳞癌患者表皮生长因子受体酪氨酸激酶抑制剂的疗效
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2025-04-17 DOI: 10.1097/MJT.0000000000001965
Yin Jie, Du Mingzhan, Gong Yinhua, Shen Dan
{"title":"The Decrease of PD-L1 Expression Affects the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Lung Squamous Cell Carcinoma.","authors":"Yin Jie, Du Mingzhan, Gong Yinhua, Shen Dan","doi":"10.1097/MJT.0000000000001965","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001965","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143960344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Myelodysplastic Syndrome Accompanied by Monoclonal Gammopathy of Undetermined Significance and Blastic Plasmacytoid Dendritic Cell Neoplasm Treated by Venetocla + Azacitidine. Venetocla +阿扎胞苷治疗骨髓增生异常综合征伴意义不明的单克隆伽玛病和母细胞浆细胞样树突状细胞肿瘤。
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2025-04-17 DOI: 10.1097/MJT.0000000000001905
Hua-Yun Geng, Juan Zheng, Guang-Yao Li
{"title":"Myelodysplastic Syndrome Accompanied by Monoclonal Gammopathy of Undetermined Significance and Blastic Plasmacytoid Dendritic Cell Neoplasm Treated by Venetocla + Azacitidine.","authors":"Hua-Yun Geng, Juan Zheng, Guang-Yao Li","doi":"10.1097/MJT.0000000000001905","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001905","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143972854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mapping the Use of Ketamine in Treatment-Resistant Depression and Other Psychiatric Disorders: A Scoping Review of Practice Patterns, Efficacy, and Patient Demographic Trends. 绘制氯胺酮在难治性抑郁症和其他精神疾病中的使用:实践模式、疗效和患者人口趋势的范围审查。
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2025-04-15 DOI: 10.1097/MJT.0000000000001951
Amna M Aslam, Kenneth Shinozuka, Owen Muir, Burton J Tabaac
{"title":"Mapping the Use of Ketamine in Treatment-Resistant Depression and Other Psychiatric Disorders: A Scoping Review of Practice Patterns, Efficacy, and Patient Demographic Trends.","authors":"Amna M Aslam, Kenneth Shinozuka, Owen Muir, Burton J Tabaac","doi":"10.1097/MJT.0000000000001951","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001951","url":null,"abstract":"<p><strong>Background: </strong>Ketamine has emerged as a novel treatment for psychiatric disorders, particularly treatment-resistant depression (TRD). Although intravenous (IV) ketamine is not approved by the Food and Drug Administration (FDA) for TRD, esketamine, an FDA-approved therapeutic, has contributed to the widespread clinical use of off-label IV ketamine across the United States. This scoping review highlights significant shifts in ketamine therapy, particularly after FDA approval of esketamine, the impact of COVID-19 on treatment accessibility, and increased regulatory scrutiny from the Drug Enforcement Administration (DEA) and FDA.</p><p><strong>Areas of uncertainty: </strong>What are the current practice patterns, patient demographics, and barriers to accessing ketamine for psychiatric disorders, particularly TRD?</p><p><strong>Data sources: </strong>This scoping review focused on provider utilization patterns (including frequency of ketamine administration, provider roles, and treatment settings), preferred administration methods (IV infusions, intramuscular injections, and other routes), and patient characteristics (age, sex, socioeconomic status, and primary psychiatric diagnoses treated). The Web of Science, PubMed, CBM, MEDLINE, Cochrane Library, University Theses, and Embase databases were searched.</p><p><strong>Results: </strong>Two survey-based studies were included. IV administration was the most common method of administration reported in both studies, with alternative methods such as intramuscular and sublingual routes emerging in limited use. Patients receiving ketamine therapy were predominantly middle aged (36-64 years old), with financial barriers identified as a notable obstacle because of limited insurance coverage. Access to ketamine was limited in rural areas, illustrating the need for expanded provider networks. Private clinics exhibited greater flexibility in treatment approaches than hospital settings, which adhered to standardized protocols. The absence of long-term outcome data and variability in treatment protocols emphasize the need for standardized practices and further research.</p><p><strong>Conclusions: </strong>This scoping review highlights the widespread use of ketamine for TRD, but reveals significant variability in practice patterns and accessibility barriers. Findings emphasize the need for standardized protocols, expanded insurance coverage, and further research to optimize the role of ketamine in psychiatric care.</p>","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143956373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Newer Uterotonics With Standard-Dose Oxytocin for Postpartum Hemorrhage Prophylaxis: A Network Meta-analysis. 新型子宫强张剂与标准剂量催产素预防产后出血的比较:一项网络荟萃分析。
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2025-04-15 DOI: 10.1097/MJT.0000000000001976
Argyro Papadopoulou, Georgios Tournas, Sofoklis Stavros, Ekaterini Domali, Georgios Daskalakis
{"title":"Comparison of Newer Uterotonics With Standard-Dose Oxytocin for Postpartum Hemorrhage Prophylaxis: A Network Meta-analysis.","authors":"Argyro Papadopoulou, Georgios Tournas, Sofoklis Stavros, Ekaterini Domali, Georgios Daskalakis","doi":"10.1097/MJT.0000000000001976","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001976","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143960235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-Term Progression-Free Survival With Sunitinib in Advanced Recurrent Adrenocortical Carcinoma. 舒尼替尼治疗晚期复发性肾上腺皮质癌的长期无进展生存率。
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2025-04-11 DOI: 10.1097/MJT.0000000000001943
Ali Turker, Mahmut Buyuksimsek, İrem Kolsuz Turker, Mehmet Turker, İrfan Alisan
{"title":"Long-Term Progression-Free Survival With Sunitinib in Advanced Recurrent Adrenocortical Carcinoma.","authors":"Ali Turker, Mahmut Buyuksimsek, İrem Kolsuz Turker, Mehmet Turker, İrfan Alisan","doi":"10.1097/MJT.0000000000001943","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001943","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143960342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring External Complementary Therapeutic Methods for Knee Osteoarthritis: Implications for Clinical Practice. 探索膝关节骨关节炎的外部辅助治疗方法:对临床实践的影响。
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2025-04-11 DOI: 10.1097/MJT.0000000000001953
Qi Yang, Jian-Jun Dong, Jiong Du, Jing Wang, Yun-Da Li, Cheng-Hao Ma, Hai-Ping Hong
{"title":"Exploring External Complementary Therapeutic Methods for Knee Osteoarthritis: Implications for Clinical Practice.","authors":"Qi Yang, Jian-Jun Dong, Jiong Du, Jing Wang, Yun-Da Li, Cheng-Hao Ma, Hai-Ping Hong","doi":"10.1097/MJT.0000000000001953","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001953","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143962306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信